Drugs / MVA-NP+M1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00942071 | Aug 2008 → Nov 2012 | influenza | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-NP+M1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00942071 ↗ |
| Modality | Vaccine | “viral-vectored influenza vaccine” PMID 23118984 ↗ Oct 2012 |